While mRNA vaccines were great in the COVID situation, they have been in development over the last decade and I'm not sure an HIV vaccine will be as simple as p

While mRNA vaccines were great in the COVID situation, they have been in development over the last decade and I'm not sure an HIV vaccine will be as simple as putting HIV envelope protein into this technology. I'm not aware of attributes to the mRNA technologies that will dramatically simplify the development challenges. I believe the more substantial step for is that we (Pharma, Investors, Governments)now realize infectious diseases are a problem for people beyond the developing world. Will that commitment hold?